Current Peptide Compliance

For peptide companies looking beyond the US market, international registration introduces a new layer of regulatory complexity. The European Medicines Agency (EMA), UK’s MHRA, and Health Canada each maintain distinct requirements for peptide products, and a strategy that works domestically may not translate internationally without significant adaptation.

EMA Requirements

The European regulatory pathway for peptide products depends on their classification. Synthetic peptides under 40 amino acids are generally regulated as chemical entities under the centralized or decentralized marketing authorization procedures. Larger peptides may fall under biological product frameworks. In either case, EMA expects comprehensive quality dossiers following the Common Technical Document (CTD) format, including detailed characterization, validated manufacturing processes, and ICH-compliant stability data. GMP compliance must be demonstrated through EU-GMP certification or equivalent.

MHRA Post-Brexit

Since Brexit, the UK has operated an independent regulatory framework through the MHRA. While many requirements parallel EU standards, the MHRA has introduced its own marketing authorization pathways, inspection schedules, and pharmacovigilance requirements. Companies must now maintain separate UK and EU regulatory strategies, including distinct Qualified Persons for pharmacovigilance and separate adverse event reporting channels.

Health Canada Pathway

Health Canada regulates peptides through its Drug Submission processes, with requirements that blend elements of both FDA and EMA frameworks. The Drug Master File system allows API manufacturers to submit proprietary information directly to Health Canada, and the regulatory review process generally follows ICH guidelines. Good Manufacturing Practice compliance is assessed through Health Canada’s inspection program or through reliance on FDA or EMA inspection reports under mutual recognition agreements.

Planning to take your peptide products international? Current Peptide Compliance provides multi-jurisdictional regulatory strategy and submission support. Start the conversation.